← Leaderboards
Rakesh K Singh
University Of Nebraska Medical Center
$2,572,515
Attributed
$3,568,408
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $402.6K · FY2005–22$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,568,408 · 4
By mechanism
R01$2,572,191 · 2
U54$687,752 · 1
R29$308,465 · 1
Top collaborators
- Surinder Kumar Batra5 shared
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Anuja Ghorpade$11,383,660
- Ying Yan$1,295,701
Others in their field
Top investigators on “Endothelial Cells”
- Keri Hammel · The Emmes Company, Llc$41,089,609
- Martin Friedlander · Scripps Research Institute$38,298,285
- Michael Simons · Yale University$37,176,481
- Ajit P Varki · University Of California San Diego$34,208,221
- Joseph C Wu · Stanford University$33,648,524
- Jan E Schnitzer · Sidney Kimmel Cancer Center$31,414,677
Research focus
Endothelial CellsNeoplastic CellSignal TransductionTumor GrowthPlayAngiogenesisPhenotypeProgramsTumorNeoplasm MetastasisTherapeutic TargetIl8rb GeneCellsLeukocytesAreaMalignant NeoplasmsInflammatoryAnimal ModelInflammationLigandsDensityCytokineChemokineCessation Of Life
Grant awards (15)
Targeting CXCR2 axis in Pancreatic Cancer$394,508
R01 · FY2022 · CA · contact PI
Targeting CXCR2 axis in Pancreatic Cancer$402,559
R01 · FY2021 · CA · contact PI
Targeting CXCR2 axis in Pancreatic Cancer$402,559
R01 · FY2020 · CA · contact PI
Targeting CXCR2 axis in Pancreatic Cancer$390,482
R01 · FY2019 · CA · contact PI
Targeting CXCR2 axis in Pancreatic Cancer$401,679
R01 · FY2018 · CA · contact PI
CXCR2-Dependent Pancreatic Cancer Progression and Metastasis$178,969
U54 · FY2015 · CA · contact PI
CXCR2-Dependent Pancreatic Cancer Progression and Metastasis$175,068
U54 · FY2014 · CA · contact PI
CXCR2-Dependent Pancreatic Cancer Progression and Metastasis$154,630
U54 · FY2013 · CA · contact PI
CXCR2-Dependent Pancreatic Cancer Progression and Metastasis$179,085
U54 · FY2012 · CA · contact PI
Molecular Regulation of Human Melanoma Metastasis$188,167
R01 · FY2007 · CA · contact PI
Molecular Regulation of Human Melanoma Metastasis$193,787
R01 · FY2006 · CA · contact PI
Molecular Regulation of Human Melanoma Metastasis$198,450
R01 · FY2005 · CA
MOLECULAR REGULATION OF HUMAN MELANOMA METASTASIS$104,040
R29 · FY2002 · CA
MOLECULAR REGULATION OF HUMAN MELANOMA METASTASIS$102,857
R29 · FY2001 · CA
MOLECULAR REGULATION OF HUMAN MELANOMA METASTASIS$101,568
R29 · FY2000 · CA